U.S., March 5 -- ClinicalTrials.gov registry received information related to the study (NCT07448558) titled 'Tailored Exercise to Reduce Aromatase Inhibitor Associated Musculoskeletal Symptoms' on Feb. 26.
Brief Summary: A randomized controlled study evaluating effect of tailored exercise compared to routine practice as a preventive measure of aromatase inhibitor associated musculoskeletal related symptoms in early breast cancer patients
Study Start Date: Feb. 18
Study Type: INTERVENTIONAL
Condition:
Patients With Early Breast Cancer Who Initiating Adjuvant Aromatase Inhibitor
Intervention:
BEHAVIORAL: tailored exercise
tailored suitable exercise to individuals recommended for the aim of aerobic exercise at 150 minutes per week and ...